These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32871647)

  • 1. A cell function study on calcium regulation of a novel calcium-sensing receptor mutation (p.Tyr825Phe).
    Moon JE; Yang HY; Wee G; ParK SH; Ko CW
    Ann Pediatr Endocrinol Metab; 2021 Mar; 26(1):24-30. PubMed ID: 32871647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating Mutations of the G-protein Subunit α 11 Interdomain Interface Cause Autosomal Dominant Hypocalcemia Type 2.
    Gorvin CM; Stokes VJ; Boon H; Cranston T; Glück AK; Bahl S; Homfray T; Aung T; Shine B; Lines KE; Hannan FM; Thakker RV
    J Clin Endocrinol Metab; 2020 Mar; 105(3):952-63. PubMed ID: 31820785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-sensing receptor residues with loss- and gain-of-function mutations are located in regions of conformational change and cause signalling bias.
    Gorvin CM; Frost M; Malinauskas T; Cranston T; Boon H; Siebold C; Jones EY; Hannan FM; Thakker RV
    Hum Mol Genet; 2018 Nov; 27(21):3720-3733. PubMed ID: 30052933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CASR gene activating mutations in two families with autosomal dominant hypocalcemia.
    Guarnieri V; Valentina D'Elia A; Baorda F; Pazienza V; Benegiamo G; Stanziale P; Copetti M; Battista C; Grimaldi F; Damante G; Pellegrini F; D'Agruma L; Zelante L; Carella M; Scillitani A
    Mol Genet Metab; 2012 Nov; 107(3):548-52. PubMed ID: 22789683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characterization of a novel calcium sensing receptor genetic alteration in a Greek patient with autosomal dominant hypocalcemia type 1.
    Papadopoulou A; Gole E; Melachroinou K; Trangas T; Bountouvi E; Papadimitriou A
    Hormones (Athens); 2017 Apr; 16(2):200-204. PubMed ID: 28742508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo a novel variant of CaSR gene in a neonate with congenital hypoparathyroidism.
    Moon JE; Lee SJ; Park SH; Kim J; Jin DK; Ko CW
    Ann Pediatr Endocrinol Metab; 2018 Jun; 23(2):107-111. PubMed ID: 29969884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel calcium-sensing receptor cytoplasmic tail deletion mutation causing autosomal dominant hypocalcemia: molecular and clinical study.
    Obermannova B; Sumnik Z; Dusatkova P; Cinek O; Grant M; Lebl J; Hendy GN
    Eur J Endocrinol; 2016 Apr; 174(4):K1-K11. PubMed ID: 26764418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH).
    Dong B; Endo I; Ohnishi Y; Kondo T; Hasegawa T; Amizuka N; Kiyonari H; Shioi G; Abe M; Fukumoto S; Matsumoto T
    J Bone Miner Res; 2015 Nov; 30(11):1980-93. PubMed ID: 25967373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino alcohol- (NPS-2143) and quinazolinone-derived calcilytics (ATF936 and AXT914) differentially mitigate excessive signalling of calcium-sensing receptor mutants causing Bartter syndrome Type 5 and autosomal dominant hypocalcemia.
    Letz S; Haag C; Schulze E; Frank-Raue K; Raue F; Hofner B; Mayr B; Schöfl C
    PLoS One; 2014; 9(12):e115178. PubMed ID: 25506941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional evaluation of a novel nonsense variant of the calcium-sensing receptor gene leading to hypocalcemia.
    Saglia C; Arruga F; Scolari C; Kalantari S; Albanese S; Bracciamà V; Corso Faini A; Brach Del Prever G; Luca M; Romeo C; Mioli F; Migliorero M; Tessaris D; Carli D; Amoroso A; Vaisitti T; De Sanctis L; Deaglio S
    Eur J Endocrinol; 2024 Mar; 190(4):296-306. PubMed ID: 38561929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of D410E, a novel mutation in the loop 3 domain of CASR, in autosomal dominant hypocalcemia and a therapeutic approach using a novel calcilytic, AXT914.
    Park SY; Mun HC; Eom YS; Baek HL; Jung TS; Kim CH; Hong S; Lee S
    Clin Endocrinol (Oxf); 2013 May; 78(5):687-93. PubMed ID: 23009664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation of the primary protein kinase C phosphorylation site in the calcium-sensing receptor causes autosomal dominant hypocalcemia.
    Lazarus S; Pretorius CJ; Khafagi F; Campion KL; Brennan SC; Conigrave AD; Brown EM; Ward DT
    Eur J Endocrinol; 2011 Mar; 164(3):429-35. PubMed ID: 21135065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Calcilytic Agent NPS 2143 Rectifies Hypocalcemia in a Mouse Model With an Activating Calcium-Sensing Receptor (CaSR) Mutation: Relevance to Autosomal Dominant Hypocalcemia Type 1 (ADH1).
    Hannan FM; Walls GV; Babinsky VN; Nesbit MA; Kallay E; Hough TA; Fraser WD; Cox RD; Hu J; Spiegel AM; Thakker RV
    Endocrinology; 2015 Sep; 156(9):3114-21. PubMed ID: 26052899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.
    Bai M; Janicic N; Trivedi S; Quinn SJ; Cole DE; Brown EM; Hendy GN
    J Clin Invest; 1997 Apr; 99(8):1917-25. PubMed ID: 9109436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal Dominant Hypocalcemia With Atypical Urine Findings Accompanied by Novel
    Tsuji T; Hiroyuki A; Uraki S; Doi A; Morita S; Iwakura H; Nishi M; Furuta H; Akamizu T
    J Endocr Soc; 2021 Mar; 5(3):bvaa190. PubMed ID: 33506158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia.
    Kinoshita Y; Hori M; Taguchi M; Watanabe S; Fukumoto S
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E363-8. PubMed ID: 24297799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diseases associated with calcium-sensing receptor.
    Vahe C; Benomar K; Espiard S; Coppin L; Jannin A; Odou MF; Vantyghem MC
    Orphanet J Rare Dis; 2017 Jan; 12(1):19. PubMed ID: 28122587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel activating mutation in calcium-sensing receptor gene associated with a family of autosomal dominant hypocalcemia.
    Okazaki R; Chikatsu N; Nakatsu M; Takeuchi Y; Ajima M; Miki J; Fujita T; Arai M; Totsuka Y; Tanaka K; Fukumoto S
    J Clin Endocrinol Metab; 1999 Jan; 84(1):363-6. PubMed ID: 9920108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and functional analysis of a novel CaSR mutation in a family with familial hypocalciuric hypercalcemia.
    Kim ES; Kim SY; Lee JY; Han JH; Sohn TS; Son HS; Moon SD
    J Bone Miner Metab; 2016 Nov; 34(6):662-667. PubMed ID: 26386835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into calcium-sensing receptor trafficking and biased signalling by studies of calcium homeostasis.
    Gorvin CM
    J Mol Endocrinol; 2018 Jul; 61(1):R1-R12. PubMed ID: 29599414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.